发明名称 CRYSTALLINE FORMS OF 1-(2-((1R,3S,5R)-3-(((R)-1-(3-chloro-2-fluorophenyl)ethyl)carbamoyl)-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)-1Hpyrazolo[3,4-c]pyridine-3-carboxamide
摘要 Crystalline forms of 11-(2-((1R,3S,5R)-3-(((R)-1-(3-chloro-2-fluorophenyl)ethyl)carbamoyl)-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)-1H- pyrazolo[3,4-c]pyridine-3-carboxamide. 1-(2-((1R,3S,5R)-3-(((R)-1-(3-chloro-2-fluorophenyl)ethyl)carbamoyl)-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)-1H- pyrazolo[3,4-c]pyridine-3-carboxamide is useful in treating a disorder or a disease in a subject mediated by complement activation, in particular mediated by activation of the complement alternative pathway.
申请公布号 WO2014002059(A1) 申请公布日期 2014.01.03
申请号 WO2013IB55301 申请日期 2013.06.27
申请人 NOVARTIS AG;TOWLER, CHRISTOPHER;ALTMANN, EVA;HOMMEL, ULRICH;LORTHIOIS, EDWIGE LILIANE JEANNE;MAIBAUM, JUERGEN KLAUS;OSTERMANN, NILS;QUANCARD, JEAN;RANDL, STEFAN ANDREAS;SIMIC, OLIVER;VULPETTI, ANNA 发明人 TOWLER, CHRISTOPHER;ALTMANN, EVA;HOMMEL, ULRICH;LORTHIOIS, EDWIGE LILIANE JEANNE;MAIBAUM, JUERGEN KLAUS;OSTERMANN, NILS;QUANCARD, JEAN;RANDL, STEFAN ANDREAS;SIMIC, OLIVER;VULPETTI, ANNA;ROGEL, OLIVIER
分类号 C07D471/04;A61K31/437;A61P27/02 主分类号 C07D471/04
代理机构 代理人
主权项
地址